Which peptides have no FDA approval and no FDA compounding review?
Short answer
16 substances profiled here have neither an FDA approval nor an FDA compounding review in the sources their profiles cite: 5-Amino-1MQ, Aviptadil, Cerebrolysin, Cibinetide, Cotadutide, Efinopegdutide, Follistatin-344, FOXO4-DRI, Hexarelin, Humanin, IGF-1 LR3, Larazotide, SLU-PP-332, Tesofensine, Thymopentin and Thymosin beta-4.
Each entry below quotes its profile and links to the full answer there.
5-Amino-1MQ
Not a peptide: a small molecule often looked up alongside peptides
Cerebrolysin
Not a single peptide: a mixture often looked up alongside peptides
No FDA approval reported; studied in clinical trials2,10
FDA’s compounding safety-risk page, current as of April 22, 2026, does not list efinopegdutide.2
Is efinopegdutide FDA-approved? · Efinopegdutide vs Survodutide
Follistatin-344
Not a peptide: a protein, larger than a peptide, often looked up alongside peptides
FDA’s compounding safety-risk page, current as of April 22, 2026, does not list hexarelin, either in category 2 or among withdrawn nominations.2
IGF-1 LR3
Not a peptide: a protein, larger than a peptide, often looked up alongside peptides
SLU-PP-332
Not a peptide: a small molecule often looked up alongside peptides
Tesofensine
Not a peptide: a small molecule often looked up alongside peptides
FDA’s compounding safety-risk page, current as of April 22, 2026, lists “thymosin beta-4, fragment (LKKTETQ), also known as TB-500” among withdrawn nominations with possible safety risks. It does not list full-length thymosin beta-4.2
Is thymosin beta-4 FDA-approved? · TB-500 vs Thymosin beta-4 · Thymosin alpha-1 vs Thymosin beta-4
PeptideScanner reports what the cited sources say. It is not medical advice and does not recommend using, buying or dosing any substance. Read the full disclaimer.
Citations
Sources
Numbered markers in the text point here. Each link opens the original public record.
- 15-Amino-1-methylquinolinium substance identity record ↗
FDA Global Substance Registration System · Official source · Source checked November 16, 2026
- 2Certain bulk drug substances for use in compounding that may present significant safety risks ↗
U.S. Food and Drug Administration · Official source · Source checked November 14, 2026
- 3Aviptadil substance identity record ↗
FDA Global Substance Registration System · Official source · Source checked November 15, 2026
- 4Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial (2023) · PMID 37348524 ↗
The Lancet Respiratory Medicine · Official source · Source checked November 15, 2026
- 5Cerebrolysin substance identity record ↗
FDA Global Substance Registration System · Official source · Source checked November 16, 2026
- 6Cibinetide (ARA 290) substance identity record ↗
FDA Global Substance Registration System · Official source · Source checked November 15, 2026
- 7Cibinetide Improves Corneal Nerve Fiber Abundance in Patients With Sarcoidosis-Associated Small Nerve Fiber Loss and Neuropathic Pain (2017) · PMID 28475703 ↗
Investigative Ophthalmology & Visual Science · Official source · Source checked November 15, 2026
- 8Cotadutide substance identity record ↗
FDA Global Substance Registration System · Official source · Source checked November 15, 2026
- 9Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study (2021) · PMID 34016612 ↗
Diabetes Care · Official source · Source checked November 15, 2026
- 10Efinopegdutide substance identity record ↗
FDA Global Substance Registration System · Official source · Source checked November 16, 2026
- 11Follistatin (activin-binding protein) substance identity record ↗
FDA Global Substance Registration System · Official source · Source checked November 16, 2026
- 12Targeted apoptosis of senescent cells restores tissue homeostasis in response to chemotoxicity and aging (2017) · PMID 28340339 ↗
Cell · Official source · Source checked November 16, 2026
- 13Examorelin (hexarelin) substance identity record ↗
FDA Global Substance Registration System · Official source · Source checked November 15, 2026
- 14Humanin substance identity record ↗
FDA Global Substance Registration System · Official source · Source checked November 16, 2026
- 15Long-(Arg3) insulin-like growth factor-I (IGF-1 LR3) substance identity record ↗
FDA Global Substance Registration System · Official source · Source checked November 16, 2026
- 16Larazotide substance identity record ↗
FDA Global Substance Registration System · Official source · Source checked November 15, 2026
- 17Larazotide acetate for persistent symptoms of celiac disease despite a gluten-free diet: a randomized controlled trial (2015) · PMID 25683116 ↗
Gastroenterology · Official source · Source checked November 15, 2026
- 18SLU-PP-332 (4-hydroxybenzoic acid 2-(2-naphthalenylmethylene)hydrazide) substance identity record ↗
FDA Global Substance Registration System · Official source · Source checked November 16, 2026
- 19Tesofensine substance identity record ↗
FDA Global Substance Registration System · Official source · Source checked November 16, 2026
- 20Thymopentin substance identity record ↗
FDA Global Substance Registration System · Official source · Source checked November 16, 2026
- 21Thymosin beta-4 substance identity record ↗
FDA Global Substance Registration System · Official source · Source checked November 15, 2026